Objective. Hypoglycemia is a common acute complication of diabetes therapy. The GlucoWatch biographer provides frequent and automatic glucose measurements with an adjustable low-glucose alarm. We have ...

Cygnus' products are designed to provide more data to individuals and their physicians and enable them to make better-informed decisions on how to manage diabetes. The three generations of Cygnus' ...

A Redwood City firm will begin selling a wristwatchlike device today that allows adult diabetics to continuously monitor their glucose levels -- with only one or two blood prick tests a day. The ...

Parsippany, NJ, and Redwood City, CA, April 24, 2003 -- A study published in the current issue of Pediatrics showed that children who wore the GlucoWatch Biographer had greater detection of ...

But Cygnus says patients can program the GlucoWatch to sound an alarm before glucose plummets to dangerous levels, giving time for a blood test.Also, the watch won’t measure if the patient’s arm ...

GlucoWatch G2 Biographer, the only noninvasive glucose monitor with FDA approval.(click to enlarge) In late March, insulin pump manufacturer Animas Corp. (West Chester, PA) completed its purchase of ...

Sept. 5 -- For diabetics, an accurate blood sugar reading could mean the difference between life and death. Current devices that measure blood sugar, or glucose, require patients to obtain a blood ...

A wristwatch-looking device that uses tiny electric currents to painlessly monitor diabetics' blood sugar now is officially available for children to use. The Food and Drug Administration first ...

Redwood City glucose-monitoring device developer Cygnus Inc. (OTCBB: CYGN) said Thursday it was laying off 60 percent of its employees as a direct result of its dispute with Sankyo Pharma Inc. over ...

The Redwood City firm which developed a wristwatch-like blood sugar monitor for people with diabetes is suing Sankyo Pharma Inc. and Sankyo Co. Ltd. for breach of contract. Cygnus Inc. is seeking $450 ...

The results show that as the biographer low-glucose alert level is increased, TPF increases; however, FPF also increases. In the home-environment study, increasing the alert level from 3.9 to 5.6 mmol ...